Bioasis reports stock options, appointment
Bioasis Technologies reports that it has granted stock options to acquire a total of 1,367,606 common shares effective June 30, 2020. The company also announced the...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Bioasis Technologies reports that it has granted stock options to acquire a total of 1,367,606 common shares effective June 30, 2020. The company also announced the...
Attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations...
New Haven-based biotech Rallybio, founded by three former Alexion executives, pulled in nearly $93 million in its recent IPO. Rallybio is developing drugs for the treatment...
BioCT welcomes Eleanore Seibert, PhD to its Board of Directors. Eleanore is Vice President of Drug Metabolism and Pharmacokinetics within the Research and Development organization at Boehringer...
The John B. Pierce Laboratory, a nonprofit, independent research institute affiliated with Yale University, recently named a new laboratory director and the first female president...
Enko has announced details on its partnership with Bayer to develop diverse chemistries for crop protection. Applying drug discovery approaches from pharma to crop protection...
Branford-based medical technology company IsoPlexis is looking to go public. Founded by Yale students in 2013, the company has developed technology that can help doctors develop...
The FDA has designated Thetis Pharmaceuticals’ experimental treatment for pancreatic cancer an “orphan drug,” a label that makes the company eligible for tax credits and other...
New Haven-born Alexion Pharmaceuticals, whose blockbuster blood-disorder drug Soliris made it one of the Elm City’s biggest biotech success stories a decade ago, is now...
InveniAI® has completed a milestone in its collaboration with PRISM BioLab. The milestone marks completion of the identification and validation of a small molecule drug candidate...